Dr. Tanguy Seiwert on the Increasing Efficacy of Immunotherapies in Head and Neck Cancer
March 5th 2016Seiwert says in general, immunotherapies produce a response rate of between 20- to 25%, 1 in 4 patients respond, and the treatment type is equally effective in both HPV-positive and HPV-negative disease.